Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 17: 274-280, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006080926
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jofré, R.
Right arrow Articles by Pérez-Garcia, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jofré, R.
Right arrow Articles by Pérez-Garcia, R.

Supplement Articles

Inflammatory Syndrome in Patients on Hemodialysis

Rosa Jofré, Patrocinio Rodriguez-Benitez, Juan M. López-Gómez and Rafael Pérez-Garcia

Servicio de Nefrología, Hospital Gregorio Marañón, Madrid, Spain

Address correspondence to: Dr. Juan M. López Gómez, Dialysis Unit, Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain. Phone: +34-91-426-5140; Fax: +34-91-586-8315; E-mail: juanmlopez{at}senefro.org

Mortality is markedly elevated in hemodialysis (HD) patients. Between 30 and 50% of prevalent patients have elevated serum levels of inflammatory markers such as C-reactive protein and IL-6. The presence of inflammation, chronic or episodic, has been found to be associated with increased mortality risk. The causes of inflammation are multifactorial and include patient-related factors, such as underlying disease, comorbidity, oxidative stress, infections, obesity, and genetic or immunologic factors, or on the other side, HD-related factors, mainly depending on the membrane biocompatibility and dialysate quality. The adequate knowledge of these causes and their prevention or treatment if possible may contribute to improving the inflammatory state of patients who are on HD and possibly their mortality.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
J. T. Park, T. I. Chang, D. K. Kim, J. E. Lee, H. Y. Choi, H. W. Kim, J. H. Chang, S. Y. Park, E. Kim, T.-H. Yoo, et al.
Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis
Nephrol. Dial. Transplant., September 25, 2009; (2009) gfp498v1.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann
Chronic Kidney Disease: Effects on the Cardiovascular System
Circulation, July 3, 2007; 116(1): 85 - 97.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673